Northwest & Ethical Investments’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-11,570
Closed -$203K 456
2021
Q3
$203K Buy
11,570
+597
+5% +$10.5K 0.01% 367
2021
Q2
$106K Buy
10,973
+7,350
+203% +$71.2K ﹤0.01% 390
2021
Q1
$38.8K Buy
3,623
+129
+4% +$1.38K ﹤0.01% 396
2020
Q4
$51.4K Buy
+3,494
New +$51.4K ﹤0.01% 392